��������

The Scientific Research Team at Olaris focuses on advancing the company’s cutting-edge metabolomics platform. Comprising experts in metabolite analysis, data science, and strategic scientific guidance, the team collaborates to identify and validate novel biomarkers of response (BoR). Their research aims to enhance the precision of disease diagnosis and treatment, ultimately improving patient outcomes by distinguishing drug responders from non-responders.